Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · Real-Time Price · USD

22.39

+0.17 (0.77%)

At close: Sep 26, 2025, 4:00 PM EDT

22.37

-0.02 (-0.09%)

After-hours: Sep 26, 2025, 4:43 PM EDT

Apellis Pharmaceuticals Market Cap

Apellis Pharmaceuticals has a market cap or net worth of $2.83 billion as of September 26, 2025. Its market cap has decreased by -39.52% in one year.

Market Cap

2.83B

Enterprise Value

2.92B

1-Year Change

-39.52%

Ranking

#1755

Market Cap Chart

Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.83B, an increase of 308.80%. That is a compound annual growth rate of 19.55%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	2.83B	-28.83%
Dec 31, 2024	3.97B	-44.04%
Dec 29, 2023	7.09B	24.06%
Dec 30, 2022	5.72B	24.22%
Dec 31, 2021	4.60B	6.25%
Dec 31, 2020	4.33B	121.45%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	646.08B
Johnson & Johnson	432.01B
AbbVie	387.42B
UnitedHealth Group	312.04B
Novo Nordisk	251.02B
Novartis AG	237.03B
Abbott Laboratories	232.77B
AstraZeneca	226.78B

Market Cap Rankings